Clinical trial
Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam…
NCT00104741 · UNICANCER, Other · Completed
Key facts
| NCT number | NCT00104741 |
|---|---|
| Title | Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer |
| Official title | Multicentre Randomized Trial Assessing the Efficacy of a Short Neoadjuvant and Concomitant Hormone Therapy to an Exclusive Curative Cornformational Radiotherapy of Locolized Prostate Cancer With Intermediate Prognosis |
| Lead sponsor | UNICANCER, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Drug, Radiation |
| Interventions | flutamide, triptorelin, radiation therapy |
| Enrollment | 378 |
| Start date | Sep 10, 2003 |
| Primary completion | Oct 1, 2015 |
| Completion | Oct 15, 2015 |
| First posted | Mar 4, 2005 |
| Last update posted | Feb 21, 2021 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: